HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antibac Soap Decline Likely In Reaction To Triclosan Debate

This article was originally published in The Rose Sheet

Executive Summary

FDA’s recent proposal to amend the OTC antiseptic drug product monograph could impact sales of antibacterial soaps, according to analysts from market research firm Kline & Company. Firms will “likely choose the path of least resistance” and replace controversial ingredient triclosan, they predict.

You may also be interested in...



Minnesota First State To Ban Triclosan In Personal Cleansing Products

Minnesota Governor Mark Dayton has signed a bill that will ban personal cleansing products that contain triclosan from sale in the state, beginning Jan. 1, 2017. The legislation exempts products approved for consumer use by FDA, which currently is reevaluating the safety and efficacy of ingredients in antibacterial soaps used by consumers.

Antibacterial Soaps Reduce Risk Of Foodborne Illness – Industry Study

A study funded in part by the Personal Care Products Council found use of antibacterial treatments to reduce concentrations of Shigella bacteria on participants’ hands significantly, leading to reduced levels transferred to melon balls and compelling estimates of reduced illness in eaters. FDA has requested such data as it considers GRASE conditions for antibacterial washes under a proposed rule issued in December 2013 that could require manufacturers to reformulate and relabel products.

FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling

FDA proposes to amend the OTC antiseptic drug product monograph to require more detailed safety and efficacy tests, pointing to mounting data that shows antibacterial wash products could pose health risks and contribute to increase antibacterial resistance.

Related Companies

UsernamePublicRestriction

Register

RS019123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel